Teresa Cavanaugh received her Doctor of Pharmacy Degree from the University of Cincinnati College of Pharmacy in 2006. Upon graduation, she completed a pharmacy practice residency at The University Hospital in Cincinnati, which solidified her interest in practice-based research with transplant patients. She then completed a two-year fellowship in health outcomes research with a focus on liver transplantation. During her fellowship, she received board certification as a pharmacotherapy specialist, and a Master of Science degree in pharmacy administration with an emphasis on health outcomes research. Dr. Cavanaugh joined the faculty of the University of Cincinnati College of Pharmacy in 2009. Her practice site was an ambulatory liver transplant clinic. Dr. Cavanaugh was actively involved in both the American Society of Health-System Pharmacists where she served as Vice Chair and Chair of the Commission on Affiliate Relations and with the Ohio Society of Health-System Services where she served two terms as division director for Organizational Affairs and was elected president in 2014. In 2016, Dr. Cavanaugh became introductory pharmacy practice experiences coordinator and the co-curricular activities coordinator. She was promoted to clinical associate professor of pharmacy practice in August 2017. Her current research interests involve student mental health and identifying characteristics that lead to success in pharmacy school.
- Pharm.D., University of Cincinnati College of Pharmacy
- M.S. Pharmacy Administration, University of Cincinnati College of Pharmacy
- Health Outcomes Research Fellowship, University of Cincinnati College of Pharmacy
- Pharmacy Practice Residency, Health Alliance, The University Hospital, Cincinnati, Ohio
- American Society of Health-System Pharmacists
- American Association of Colleges of Pharmacy
- American Pharmacists Association
- American College of Clinical Pharmacy
- Student mental health
- Health outcomes
|“Comparative effectiveness of tacrolimus-based steroid sparing versus steroid maintenance regimens in kidney transplantation: Results from discrete event simulation” Desai, VCA, Ferrand Y, Cavanaugh TM, Kelton CML, Caro JJ, Goebel J, Heaton PC. Medical Decision Making. 2017; 37(7):827-43.
|“Off-label use of oral fluoroquinolone antibiotics in outpatient settings in the United States, 2006-2012” Almalki ZS, Alahmari AK, Guo JJ, Cavanaugh TM. Pharmacoepidemiology and Drug Safety. 2016 Sep;25(9):1042-51
|“TransitionRx: Impact of community pharmacy post discharge medication therapy management on hospital readmission rate” Luder HR, Frede SM, Kirby JA, Epplen K, Cavanaugh T, Martin-Boone JE, Conrad WF, Kuhlmann D, Heaton PC. J Am Pharm Assoc 2015;55:246-54
|“Comparative Persistence of -Blockers versus Calcium Channel Blockers in the Treatment of Atrial Fibrillation in Nonelderly Adult Patients” Desai VC, Kelton CML, Metzger AH, Cavanaugh TM, Guo JJ, Heaton PC. Annals of Pharmacotherapy 2014 Dec;48(12):1570-9
|“A pharmacoeconomics and formulary management collaborative project to teach decision analysis principles.” Cavanaugh TM, Buring S, Cluxton R. American Journal of Pharmaceutical Education 2012;76(6).
|“The impact of sirolimus on sex hormones in male adolescent kidney recipients.” Cavanaugh TM, Schoenemen H, Goebel J. Pediatric Transplantation 2012 May;16(3):280-285.
|“The Impact of a Change in Tacrolimus Monitoring Immunoassay Techniques on Clinical Decision Making and Patient Outcomes.” Cavanaugh TM, Parrish N, Neff G, Rudich S, Martin-Boone J. Transplantation Proceedings December 2010; 20(4):350-356
|“Update on Pharmacoeconomics in Transplantation.” Cavanaugh TM, Martin JE. Progress in Transplantation June 2007; 17 (2): 103-119; quiz 120